South Texas Accelerated Research Therapeutics START — San Antonio, Texas

South Texas Accelerated Research Therapeutics START is a clinical research site located in San Antonio, Texas, United States 78229.

Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.

South Texas Accelerated Research Therapeutics START has participated in 13 clinical trials with 5 currently active.

Therapeutic areas: Solid Tumors, Hematologic Malignancies, Advanced Solid Tumors.

Sponsors: Merck Sharp & Dohme LLC, Novartis Pharmaceuticals, BioNTech SE.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Antonio

Browse all research sites in Texas · View every site in San Antonio

Sponsor Feasibility Report

Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Texas Accelerated Research Therapeutics START?

South Texas Accelerated Research Therapeutics START has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Texas Accelerated Research Therapeutics START conducted?

South Texas Accelerated Research Therapeutics START has 13 clinical trials on record, with 5 currently active. Their work covers Solid Tumors, Hematologic Malignancies, Advanced Solid Tumors.

Is South Texas Accelerated Research Therapeutics START accredited by Crixeo Clinical Trials?

South Texas Accelerated Research Therapeutics START has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about South Texas Accelerated Research Therapeutics START?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.